Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine

The aim of the present study was to evaluate whether previous preventive treatment with onabotulinumtoxin-A might influence subsequent clinical response following a switch to anti-CGRP monoclonal antibodies (mAbs). The present retrospective study was conducted at the Headache Centre—Neurology Clinic...

Full description

Bibliographic Details

Published in:	Toxins
Main Authors:	Giulia Ceccardi, Francesca Schiano di Cola, Salvatore Caratozzolo, Michele Di Pasquale, Marco Bolchini, Alessandro Padovani, Renata Rao
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Subjects:	migraine chronic migraine onabotulinumtoxin A CGRP anti-CGRP monoclonal antibodies prevention
Online Access:	https://www.mdpi.com/2072-6651/15/12/677